125 related articles for article (PubMed ID: 20164435)
1. Distinct protease requirements for antigen presentation in vitro and in vivo.
Matthews SP; Werber I; Deussing J; Peters C; Reinheckel T; Watts C
J Immunol; 2010 Mar; 184(5):2423-31. PubMed ID: 20164435
[TBL] [Abstract][Full Text] [Related]
2. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
[TBL] [Abstract][Full Text] [Related]
3. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
[TBL] [Abstract][Full Text] [Related]
4. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
5. Asparaginyl endopeptidase: case history of a class II MHC compartment protease.
Watts C; Matthews SP; Mazzeo D; Manoury B; Moss CX
Immunol Rev; 2005 Oct; 207():218-28. PubMed ID: 16181339
[TBL] [Abstract][Full Text] [Related]
6. Modulation of antigen presentation and B cell receptor signaling in B cells of beige mice.
Chatterjee P; Tiwari RK; Rath S; Bal V; George A
J Immunol; 2012 Mar; 188(6):2695-702. PubMed ID: 22327079
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells.
Burster T; Reich M; Zaidi N; Voelter W; Boehm BO; Kalbacher H
Biochem Biophys Res Commun; 2008 Dec; 377(4):1299-303. PubMed ID: 18996084
[TBL] [Abstract][Full Text] [Related]
8. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
9. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
10. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
11. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP.
Manoury B; Mazzeo D; Fugger L; Viner N; Ponsford M; Streeter H; Mazza G; Wraith DC; Watts C
Nat Immunol; 2002 Feb; 3(2):169-74. PubMed ID: 11812994
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
13. Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways.
Demotz S; Matricardi PM; Irle C; Panina P; Lanzavecchia A; Corradin G
J Immunol; 1989 Dec; 143(12):3881-6. PubMed ID: 2480377
[TBL] [Abstract][Full Text] [Related]
14. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model.
Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J
J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410
[TBL] [Abstract][Full Text] [Related]
15. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
16. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.
Constant S; Schweitzer N; West J; Ranney P; Bottomly K
J Immunol; 1995 Oct; 155(8):3734-41. PubMed ID: 7561077
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
Guéry JC; Adorini L
J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
[TBL] [Abstract][Full Text] [Related]
18. Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcgammaRII.
Antoniou AN; Watts C
Eur J Immunol; 2002 Feb; 32(2):530-40. PubMed ID: 11828370
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
Svensson M; Stockinger B; Wick MJ
J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
[TBL] [Abstract][Full Text] [Related]
20. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
Kleindienst P; Brocker T
Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]